Clinical trials
Insulin Resistance trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 6 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Unknown status | 6 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Adelaide | 8 |
| Garvan Institute of Medical Research | 5 |
| Bayside Health | 3 |
| Baker Heart Research Institute | 2 |
| Monash University | 2 |
| The University of Western Australia | 2 |
| Austin Health | 1 |
| Baker Heart and Diabetes Institute | 1 |
| Boston Children's Hospital | 1 |
| Menzies Institute for Medical Research | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insulin Resistance | 32 |
| Diabetes Mellitus, Type 2 | 10 |
| Obesity | 9 |
| Inflammation | 6 |
| Cardiovascular Diseases | 4 |
| Metabolic Syndrome | 4 |
| Diabetes Mellitus | 3 |
| Dyslipidemias | 3 |
| Heart Failure | 2 |
| Hypoxia | 2 |
Trials
Showing 76 to 32 of 32. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.